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Objective To study the quality and continuity of treatment in the Acute Medicines
Assessment Unit (AMAU) with regard to empirical prescription of antibiotics, mode of
administration, adherence to ward antibiotic policy, as well as collection, awareness and
utilization of microbiological investigations.
Methods A prospective study over a 3-month period at the AMAU, Aberdeen Royal
Infirmary (ARI), a teaching hospital in north-eastern Scotland, was performed. The study
included all patients started on empirical antibiotics on admission to the AMAU and
followed up until their discharge.
Results Of 1303 patients admitted, 221 (17%) were started on empirical antibiotics. This
was in accordance with hospital antibiotic policy in 52% of cases. Appropriate specimens
were taken from 77% of patients. Culture results showed that 29% (n ¼ 65) of the patients
had clinically significant growth of organisms. Of the 65 patients with clinically sig-
nificant culture results, 49% (n ¼ 32) were on an inappropriate empirical regimen. In
55%, the medication was not changed to a more appropriate antibiotic. In 72% of the
patients with a negative culture, the culture report had no obvious effect on the duration
or type of antibiotic being administered. Intravenous antibiotics were used in 60% of
patients.
Conclusion This study demonstrates a significant overuse of antibiotics, especially
intravenous forms, despite a paucity of positive sepsis parameters and chest X-ray
findings in these patients The duration of treatment could be shortened and an early
switch policy introduced if culture results and sepsis profiles were taken into considera-
tion, as there was a large number of unproven infections. Suggestions are made about
how these improvements in prescribing could be made within the current administrative
set-up of AMAUs.
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I N T R O D U C T I O N
The successful and efficient treatment of infectious
diseases with antimicrobial agents continues to
present problems in modern medicine, with many
studies showing a significant increase in the inci-
dence of resistance worldwide [1–3]. This is
responsible for increased global healthcare costs,
because of the lack of efficacy of many first-line
drugs, and the consequent need to use more
expensive second- and third-line drugs, prolonged
periods during which individuals are infectious,
increased morbidity, increased length of hospital
stay, and even, in some cases, increased mortality
[1,4].
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
Corresponding author and reprint requests: Y. Kumarasa-
my, School of Pharmacy, The Robert Gordon University,
Schoolhill, Aberdeen AB10 1FR, UK
Tel: þ44 122 426 2522
Fax: þ44 122 426 2555
E-mail: y.kumarasamy@rgu.ac.uk
In modern medicine, most antibiotic therapy is
empirical [1]. However, inappropriate empirical
therapy is associated with poor outcomes and
excess mortality, in addition to increased anti-
biotic resistance [2,4]. One of the key issues in the
empirical usage of antibiotics lies in the drug
selection. This is complicated by the ever-increas-
ing range of antibiotics available today. Keeping
this in mind, the Grampian formulary was pre-
pared for both hospital and general practice as a
guideline for rational prescribing in the Gram-
pian region [5,6].
Another key issue is the mode of administra-
tion of antibiotics. Published studies have shown
that an early switch from intravenous to oral
antibiotics is beneficial in terms of reducing drug
costs, patient stay and hospital-related morbidity
[7,8].
The Accident and Emergency (A&E) depart-
ment offers care to patients who arrive with urgent
problems and who have usually not been seen by a
general practitioner (GP). It is an initial point of
triage, where patients may be admitted for further
treatment if deemed necessary. Currently, UK
hospitals are undergoing yet another phase of
administrative reorganization. Most major hospi-
tals now utilize an Acute Medicines Assessment
Unit (AMAU), where patients are admitted
directly or after initial triage in the A&E depart-
ment. In the AMAU, the medical emergency
admissions are assessed, stabilized, and then sent
to appropriate wards [9]. There are concerns with
this type of system with regard to the maintenance
and continuity of good quality of care, which may
be further compromised by the implementation of
the European Working Time Directive and reor-
ganization of trainees’ working time [10,11].
This study looked at the quality of treatment in
the AMAU with regard to empirical prescription
of antibiotics, type of antibiotic used, mode of
administration, degree of adherence to ward anti-
biotic policy, duration of treatment, as well as
collection, awareness and utilization of microbio-
logical investigations.
M A T E R I A L S A N D M E T H O D S
The prospective study was conducted over a 3-
month period, from 16 April 2000 to 16 July 2000.
All patients admitted to the AMAU of the Aberd-
een Royal Infirmary (ARI) who were started on
antibiotic therapy were included in the study.
The patients were identified on a daily basis by
examination of the medical and nursing notes as
well as their drug record. Patients were followed
up by one of us throughout their antibiotic treat-
ment in the hospital. There were no specific exclu-
sion criteria. Apart from the head of the unit, staff
were informed only in general terms about the
purpose of the audit.
For each patient, the following data were col-
lected prospectively: gender, age, provisional
diagnosis, major system affected, sepsis para-
meters [13], antibiotic(s) used, dose and route of
administration, frequency/dosing interval, time
delay between admission and commencement of
therapy, the types and dates of specimens col-
lected, whether the specimens were collected with
appropriate precautions, dates of the report being
viewable at ward level, dates on which the report
was noted and acted upon, and patient outcomes.
Data on chest X-ray (CXR) were collected from 1
May 2000 to 16 July 2000.
The data were analyzed using both Excel and
SPSS software packages. For analysis of two vari-
ables, a contingency table was constructed. Cross-
tabulation and chi-square analysis were used to
ascertain whether there were any significant rela-
tionships between the variables.
The antibiotic policy [6] gives guidelines on
route, dose and duration of administration and
choice if the patient is allergic to penicillin. Advice
on investigation is also given.
Definitions and criteria used
Empirical therapy: The initial use of antibiotics
before the pathogen was identified.
Inappropriate antimicrobial treatment: The bacterial
isolate was resistant to the antibiotic being used or
the antibiotic was not indicated in the susceptibil-
ity results.
Appropriate antimicrobial treatment: The empirical
therapy instituted complied with the sensitivity
data.
Appropriate specimens: The specimens taken for
laboratory examination were pertinent to the
working diagnosis.
Sepsis parameters [13]: Considered as a positive
sepsis profile if two or more of the following were
present: temperature >38 8C or <36 8C; heart rate
>90 beats/min; respiratory rate >20 breaths/min
or PaCO2<4.3 kPa; white cell count>12 000/mm
3
or <4000/mm3.
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Severe sepsis: Sepsis associated with hypotension or
organ hypoperfusion.
R E S U L T S
In total, 26 consultants admitted patients to the
AMAU. During the period of the study, 1303
patients (652 female, 651 male) were admitted to
the AMAU, of whom 221 (128 female, 93 male)
(17%) were started on empirical antibiotics.
Besides the 221 started on antibiotics in the hospi-
tal, there were 16 patients already on antibiotics
prescribed by their GP who were not considered in
the analysis.
The majority of cases started on empirical anti-
biotics had respiratory (48%, n ¼ 107) or genitour-
inary (25%, n ¼ 55) diseases. Bacteremia
accounted for about 3% (n ¼ 7) of the cases. The
mean delay from time of admission until receipt of
first dose of antibiotics, when indicated, was 7.2 h
(SD ¼  6.2 h).
In 52% (n ¼ 115) of the patients, empirical ther-
apy was in accordance with the antibiotic policy.
Of 221 patients, only 77% (n ¼ 170) had appro-
priate laboratory samples taken, of whom 38%
(n ¼ 65) had clinically significant growth of organ-
isms (Table 1). In 30% (n ¼ 51), the specimens
were taken after administration of the first dose
of antibiotics. Two of the 65 clinically significant
cases had fungal infections, and were not further
considered in the analysis. Only 29% (n ¼ 63) of
the 221 patients had culture results that merited
antibiotic treatment.
In the study of the 133 patients started on
empirical intravenous antibiotics, 72% (n ¼ 96)
of the patients had negative culture results, and
69% (n ¼ 92) had negative sepsis profiles
(Table 2). Almost half (48%, n ¼ 64) of the patients
started on intravenous antibiotics had both nega-
tive sepsis profiles and negative culture results.
The relative risk of being on an intravenous anti-
biotic in spite of a negative culture was 72%,
implying an odds ratio of 2.6. There was a trend
to a positive sepsis profile in patients treated with
intravenous antibiotics, but this was not statisti-
cally significant (P ¼ 0.178).
In a subset study (n ¼ 95), the results of CXR
were compared with culture and sepsis results:
43% (n ¼ 41) of patients with no clinically signifi-
cant CXR findings also had negative culture
results, and 41% (n ¼ 39) also had negative sepsis
profiles (Table 3). There was a trend to negative
sepsis profiles and culture results in those with
clear CXR, but this was not statistically significant
(P ¼ 0.375).
The four most commonly used antibiotics in the
AMAU were cefotaxime (35%, n ¼ 78), clarithro-






% of the total
cases on
antibiotics
Haemophilus influenzae Respiratory 10 (15.4) 4.5
Haemophilus parainfluenzae Respiratory 2 (3.1) 0.9
Streptococcus pneumoniae Respiratory 2 (3.1) 0.9
Methicillin-resistant Respiratory 5 (7.7) 2.3
Staphylococcus aureus (MRSA)
Urine 1 (1.5) 0.5
Blood 2 (3.1) 0.9
Soft tissue 8 (12.3) 3.6
Staphylococcus aureus Respiratory 1 (1.5) 0.5
(methicillin sensitive)
Genitourinary 1 (1.5) 0.5
Soft tissue 3 (4.6) 1.4
Staphylococcus aureus Blood 1 (1.5) 0.5
Acinetobacter baumanii Respiratory 2 (3.1) 0.9
Escherichia coli Blood 4 (6.2) 1.8
Escherichia coli (0157) Gastrointestinal 1 (1.5) 0.5
Coliforms Genitourinary 11 (16.9) 5.0
Pseudomonas aeruginosa Genitourinary 3 (4.6) 1.4
Enterococcus faecalis Genitourinary 3 (4.6) 1.4
Proteus spp. Genitourinary 2 (3.1) 0.9
Candida albicans Genitourinary 2 (3.1) 0.9
Streptococcus pyogenes Soft tissue 1 (1.5) 0.5
Total 65 (100) 29.4
Table 1 Isolates of clinical signifi-
cance, their percentage distribution
relative to each other, and percentage
of the total cases on empirical anti-
biotics
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and amoxicillin (8%). Combinations of antibiotics
were used in 34% (n ¼ 77) of the patients. Of the 77
patients on two or more antibiotics, the three most
common combinations used were cefotaxime–
clarithromycin (30%, n ¼ 23), cefotaxime–metro-
nidazole (21%, n ¼ 16), and benzylpenicillin–flu-
cloxacillin (10%, n ¼ 8).
Of the 63 patients with clinically significant
bacteriologic culture results, 51% (n ¼ 32) were
on an inappropriate antimicrobial agent, as shown
by the sensitivity data. Although 44% (n ¼ 14) of
these 32 patients had their medication changed to a
more suitable antibiotic, 56% (n ¼ 18) did not.
Antibiotics were discontinued in 7% (n ¼ 8) of
the patients with negative culture results, while in
9% (n ¼ 9) of the patients, treatment was stopped
within 3 days for other reasons, mainly the resolu-
tion of clinical signs of infection. In 72% (n ¼ 158)
of the patients with negative culture results, the
culture report had no obvious effect on the dura-
tion or type of antibiotic being administered.
The time of switch from intravenous to oral
antibiotics ranged from 1 to 11 days (mean ¼ 3.5 -
days). The duration of treatment ranged from 1 to
26 days (mean ¼ 8.4 days). Statistical analysis
showed no significant relationship between cul-
ture results and duration of treatment (P ¼ 0.392).
Of the patients started on empirical antibiotics,
60% (n ¼ 133) received them intravenously,
although 83% (n ¼ 110) were capable of taking
medication orally. Of the patients with negative
culture results, 72% (n ¼ 96) had been started on
intravenous antibiotics.
Documentation of results was found in 86%
(n ¼ 190) of the case notes. The time interval
between the availability of the reports and their
documentation in notes was 1 day in 85% of the
cases.
Of the 221 cases in the study, 95% (n ¼ 210) of
the patients recovered, 3.5% (n ¼ 8) were still in-
patients in a ward when the study was concluded,
and 1.8% (n ¼ 4) died.
D I S C U S S I O N
Compared to published data [14,15], the use of
empirical antibiotic therapy in the ARI is conser-
vative, with less than 17% of medical admissions
receiving antibiotics. The majority of admissions
who were started on empirical antibiotic therapy
were suffering from respiratory infections, with
urinary tract infection being the second most com-
mon indication. The collection of appropriate sam-
ples seemed reasonable at 77% (n ¼ 170), given the
difficulty of collecting sputum samples from many
patients with respiratory tract infection. However,
30% (n ¼ 51) of the specimens were taken after
administration of the first dose of antibiotics. This
Table 2 The distribution of sepsis profiles and culture results of the patients started on empirical antibiotics
A
Culture and sensitivity (c/s)
B
Sepsis profile Both c/s and
sepsis profile
NegativePositive Negative Positive Negative
Patients on intravenous
antibiotics (n ¼ 133)
37 (27.8%) 96 (72.2%) 41 (30.8%) 92 (69.2%) 64 (48.1%)
Patients on oral antibiotics
(n ¼ 88)
26 (29.5%) 62 (70.5%) 13 (14.8%) 75 (56.3%) 47 (53.4%)
Total (n ¼ 221) 63 (28.5%) 158 (71.5%) 54 (24.5%) 167 (75.1%) 111
Table 3 Results of chest X-ray, cul-
ture results and sepsis profile for the
subset of 95 patients who were
started on empirical antibiotics for
respiratory ailments
Culture results Sepsis profile
Positive Negative Positive Negative
X-ray suggests infection 10 (11%) 17 (18%) 12 (13%) 16 (17%)
X-ray does not suggest infection 14 (15) 41 (43%) 15 (16%) 39 (41%)
X-ray not done 5 (5%) 8 (8%) 4 (4%) 9 (9%)
Total (n ¼ 95) 29 (31%) 66 (69%) 31 (33%) 64 (67%)
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is an inherent flaw in the system. A requirement
for samples to be taken before antibiotic treatment
is commenced should be emphasized, provided
that delay in treatment of critically ill patients does
not ensue.
The delay of approximately 7.2 h between
admission and the administration of the first dose
of antibiotics is another area where improvement
is desirable, as published studies [16,17] have
shown that shorter time delays result in shorter
duration of stay and less morbidity. While such
delays before commencing empirical therapy do
not represent good practice in seriously ill
patients, the majority of patients admitted were
evidently not in need of urgent antibiotic therapy,
and this delay could be best used to collect results
of baseline investigations, e.g. measurement of
sepsis parameters, Gram stain, and urine micro-
scopy; even results of urine culture with direct
susceptibility testing should be available, obviat-
ing the need for therapeutic empiricism.
This study demonstrates a significant overuse of
antibiotics, which is, of course, well described [18].
There is poor utilization of culture results, parti-
cularly negative ones, to streamline or stop treat-
ment. This is also well described in the literature
[19,20].
Of the 221 patients started on empirical anti-
biotics, 60% (n ¼ 133) received them in intrave-
nous form, although 83% of these patients were
capable of taking medication orally. Of the patients
with negative culture results, 72% had been started
on intravenous antibiotics, and there was also a
paucity of positive sepsis parameters and CXR
findings in these patients. Further studies need
to be done to evaluate whether this use of intra-
venous antibiotics is justified, although this seems
unlikely. The CXR is the definitive diagnostic test
for pneumonia (BTS guidelines), and the overuse
of intravenous cephalosporins in this setting is
well described [21].
The use of oral forms of antibiotics in empirical
therapy would be ‘patient-friendly’ and would
facilitate ease of administration as well as cost-
effectiveness. Traditionally, intravenous antibio-
tics have been employed in order to quickly
achieve therapeutic levels. However, studies
[7,8] have demonstrated that similar therapeutic
levels can be achieved by the use of oral antibiotics
if a critical evaluation of each patient is carried out,
particularly in the absence of positive sepsis para-
meters. The switch from an intravenous to an oral
antibiotic was usually achieved within 3.5 days,
which is similar to results from previous audits in
the Grampian region [22–24]. There are no appar-
ent reasons why this period could not be reduced
to 24 h.
The duration of antibiotic treatment was 8 days
on average, which is similar to the findings of
previous studies from Grampian hospitals [22–
24]. The duration of treatment could be shortened
and an early switch policy could be instituted if
culture results and sepsis profiles were taken into
consideration, as there are many unproven infec-
tions.
Documentation of results in notes, at 86%,
was satisfactory compared to published studies
[25,26]. However, as the reports were often in the
form of a computer printout and tended to get
mixed up with older reports, they were frequently
not utilized unless the patient was not doing well
clinically. It would be beneficial if culture reports
were entered into the daily notes, as these are
always scrutinized by the clinicians; this could
result in a more optimal use of the microbiological
results, in particular cessation of unnecessary anti-
biotics.
C O U N T E R M E A S U R E S
Inappropriate use of antibiotics is frequently iden-
tified as an important driver of high treatment
costs, avoidable side effects, treatment failures
and antibiotic resistance [27,28].
This study suggests that antibiotic use could be
improved via a number of simple steps: (1)
increased utilization of microbiological culture
reports, microscopy and sepsis profiles; (2) more
judicious use of intravenous antibiotics and daily
review by a senior doctor, earlier switch to oral
medicines, and streamlining or discontinuing
treatment in the event of negative sepsis profiles
and culture results; (3) more clearly defined ward
protocols to guide empirical therapy, as, despite a
previous audit [22], compliance with the policy
was only 52%; and (4) where sepsis is severe,
administration of intravenous antibiotics as soon
as possible by authorized nursing staff.
One possible solution for the successful imple-
mentation of these recommendations would be the
adoption of generic antibiotic policies describing
the process of prescribing. These are currently
being piloted locally at the ARI. Audit of quality
indicators [3,12] will form an increasing part of a
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clinicians’ antibiotic-prescribing quality program
in the future, in conjunction with the Antibiotic
Committee as well as the Clinical Effectiveness,
Clinical Governance and Quality Assurance com-
mittees of the hospital trust.
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